293 related articles for article (PubMed ID: 36672019)
1. Value of Antibody Determinations in Chronic Dysimmune Neuropathies.
Tozza S; Spina E; Iovino A; Iodice R; Dubbioso R; Ruggiero L; Nolano M; Manganelli F
Brain Sci; 2022 Dec; 13(1):. PubMed ID: 36672019
[TBL] [Abstract][Full Text] [Related]
2. Chronic dysimmune neuropathies: Beyond chronic demyelinating polyradiculoneuropathy.
Khadilkar SV; Deshmukh SS; Dhonde PD
Ann Indian Acad Neurol; 2011 Apr; 14(2):81-92. PubMed ID: 21808468
[TBL] [Abstract][Full Text] [Related]
3. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients.
Busby M; Donaghy M
J Neurol; 2003 Jun; 250(6):714-24. PubMed ID: 12796835
[TBL] [Abstract][Full Text] [Related]
4. What is new in 2015 in dysimmune neuropathies?
Kuntzer T
Rev Neurol (Paris); 2016 Dec; 172(12):779-784. PubMed ID: 27866728
[TBL] [Abstract][Full Text] [Related]
5. Rituximab in chronic immune mediated neuropathies: a systematic review.
Chaganti S; Hannaford A; Vucic S
Neuromuscul Disord; 2022 Aug; 32(8):621-627. PubMed ID: 35672205
[TBL] [Abstract][Full Text] [Related]
6. Immune-Mediated Neuropathies: Pathophysiology and Management.
Shastri A; Al Aiyan A; Kishore U; Farrugia ME
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108447
[TBL] [Abstract][Full Text] [Related]
7. [Axonal involvement in dysimmune neuropathies].
Vallat JM
Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S5-11. PubMed ID: 18087224
[TBL] [Abstract][Full Text] [Related]
8. [Dysimmune neuropathies: current diagnosis and therapy].
Léger JM; Larue S; Dashi F
Rev Prat; 2008 Nov; 58(17):1887-9, 1892-4. PubMed ID: 19157204
[TBL] [Abstract][Full Text] [Related]
9. [Chronic inflammatory demyelinating neuropathies and their variants].
Vallat JM; Tabaraud F; Magy L; Macian F
Rev Neurol (Paris); 2002 Dec; 158(123):27-31. PubMed ID: 12690330
[TBL] [Abstract][Full Text] [Related]
10. How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies?
Nobile-Orazio E; Gallia F; Terenghi F; Allaria S; Giannotta C; Carpo M
J Neurol Sci; 2008 Mar; 266(1-2):156-63. PubMed ID: 17915254
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic mechanisms in inflammatory and paraproteinaemic peripheral neuropathies.
Rinaldi S; Bennett DL
Curr Opin Neurol; 2014 Oct; 27(5):541-51. PubMed ID: 25159930
[TBL] [Abstract][Full Text] [Related]
12. Treatment of immune-mediated, dysimmune neuropathies.
Finsterer J
Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
[TBL] [Abstract][Full Text] [Related]
13. [Acquired dysimmune neuropathies. Clinical symptoms and classification].
Pou-Serradell A
Rev Neurol; 2000 Mar 16-31; 30(6):501-10. PubMed ID: 10863721
[TBL] [Abstract][Full Text] [Related]
14. Causes of chronic neuropathies: a single-center experience.
Ricci L; Luigetti M; Florio L; Capone F; Di Lazzaro V
Neurol Sci; 2019 Aug; 40(8):1611-1617. PubMed ID: 31001716
[TBL] [Abstract][Full Text] [Related]
15. [Relevant antibodies in dysimmune neuropathies].
Gallardo E; Rojas R; Illa I
Rev Neurol; 2000 Mar 16-31; 30(6):510-4. PubMed ID: 10863722
[TBL] [Abstract][Full Text] [Related]
16. Immune mechanisms, the role of complement, and related therapies in autoimmune neuropathies.
Latov N
Expert Rev Clin Immunol; 2021 Dec; 17(12):1269-1281. PubMed ID: 34751638
[TBL] [Abstract][Full Text] [Related]
17. Treatment of chronic immune-mediated neuropathies: impact of the rare diseases centers network in Italy.
Nobile-Orazio E
Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S33-8. PubMed ID: 23452770
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and treatment of chronic acquired demyelinating polyneuropathies.
Latov N
Nat Rev Neurol; 2014 Aug; 10(8):435-46. PubMed ID: 24980070
[TBL] [Abstract][Full Text] [Related]
19. Clinical neurophysiology of demyelinating polyneuropathy.
Bowley MP; Chad DA
Handb Clin Neurol; 2019; 161():241-268. PubMed ID: 31307604
[TBL] [Abstract][Full Text] [Related]
20. Long-standing Multifocal Motor Neuropathy Presenting With Delayed Clinical Features of Anti-Myelin-Associated Glycoprotein Neuropathy and Elevated Anti-Myelin-Associated Glycoprotein Antibody Titers.
Bernardo KA; Weiss MD
J Clin Neuromuscul Dis; 2021 Mar; 22(3):169-172. PubMed ID: 33596002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
